A comprehensive view of Moderna Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Moderna signs contract with Brazil's Ministry of Health to supply 12.5 million doses of its mRNA COVID-19 vaccine for the 2024 national vaccination campaign; vaccine delivery expected in Q2 2024
Published:
April 22, 2024
by Moderna Inc.
|
Boston Scientific's Farapulse PulseSelect Pulsed-Field Ablation system gains foothold in the US PFA system market; J&J remains top player in electrophysiology devices market with 54% market share
Published:
April 19, 2024
by MarketLine
|
Moderna to report first quarter 2024 financial results on Thursday, May 2, 2024
Published:
April 17, 2024
by Moderna Inc.
|
Pfizer and BioNTech get temporary reprieve in patent dispute with Moderna, allowing more time for the Patent Trial and Appeal Board to review challenges; Pfizer and BioNTech’s COVID-19 vaccine to remain on the market despite lawsuit
Published:
April 15, 2024
by FiercePharma
|
Patent Application Titled 'Variant Strain-Based Coronavirus Vaccines' Published Online (USPTO 20240100151)
Published:
April 12, 2024
by CDC & FDA Daily
|
Ask us about our R&D/Patents market view